Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Detection and Intervention of Acute Contrast Media Induced Nephropathy Using Neutrophil Gelatinase-associated Lipocalin (NGAL) May Improve Renal Outcome: A Study in Patients Undergoing Intra-arterial Angiography.

NCT01292317 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT01292317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01292317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Detection and Intervention of Acute Contrast Media Induced Nephropathy Using Neutrophil Gelatinase-associated Lipocalin (NGAL) May Improve Renal Outcome: A Study in Patients Undergoing Intra-arterial Angiography.
Lead sponsor
Medical University of Graz
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2011
Completion date
December 31, 2015
Enrollment
819 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast media induced nephropathy (cin)